The phosphorylation levels of p38 have been associated with the viability of high-glucose-treated RF/6A cells and their in vivo viability in a STZ diabetic rat model [72], and inhibition of p38 protected against diabetes-induced retinal microvascular damage in rats by a mechanism involving NFκB [73]. This evidence concerns the gene MAPK1 and diabetes mellitus.